Reed B, Blaiss MS (2018) The burden of atopic dermatitis. Allergy Asthma Proc 39:406–410. https://doi.org/10.2500/aap.2018.39.4175

Article  PubMed  Google Scholar 

Chong AC, Schwartz A, Lang J et al (2024) Patients’ and caregivers’ preferences for mental health care and support in atopic dermatitis. Dermatitis 35:S70–S76. https://doi.org/10.1089/derm.2023.0111

Article  PubMed  Google Scholar 

Rønnstad ATM, Halling-Overgaard A-S, Hamann CR et al (2018) Association of atopic dermatitis with depression, anxiety, and suicidal ideation in children and adults: a systematic review and meta-analysis. J Am Acad Dermatol 79:448-456.e30. https://doi.org/10.1016/j.jaad.2018.03.017

Article  PubMed  Google Scholar 

Patel KR, Immaneni S, Singam V et al (2019) Association between atopic dermatitis, depression, and suicidal ideation: a systematic review and meta-analysis. J Am Acad Dermatol 80:402–410. https://doi.org/10.1016/j.jaad.2018.08.063

Article  PubMed  Google Scholar 

Long Q, Jin H, You X et al (2022) Eczema is a shared risk factor for anxiety and depression: a meta-analysis and systematic review. PLoS ONE 17:e0263334. https://doi.org/10.1371/journal.pone.0263334

Article  CAS  PubMed  PubMed Central  Google Scholar 

Smith Begolka W, Chovatiya R, Thibau IJ, Silverberg JI (2021) Financial burden of atopic dermatitis out-of-pocket health care expenses in the United States. Dermatitis 32:S62–S70. https://doi.org/10.1097/DER.0000000000000715

Article  PubMed  Google Scholar 

Maarouf M, Saberian C, Lio PA, Shi VY (2018) Head-and-neck dermatitis: diagnostic difficulties and management pearls. Pediatr Dermatol 35:748–753. https://doi.org/10.1111/pde.13642

Article  PubMed  Google Scholar 

Girolomoni G, de Bruin-Weller M, Aoki V et al (2021) Nomenclature and clinical phenotypes of atopic dermatitis. Ther Adv Chronic Dis 12:20406223211002980. https://doi.org/10.1177/20406223211002979

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cabanillas B, Brehler A-C, Novak N (2017) Atopic dermatitis phenotypes and the need for personalized medicine. Curr Opin Allergy Clin Immunol 17:309–315. https://doi.org/10.1097/ACI.0000000000000376

Article  PubMed  PubMed Central  Google Scholar 

Silverberg JI, Hanifin JM (2013) Adult eczema prevalence and associations with asthma and other health and demographic factors: a US population-based study. J Allergy Clin Immunol 132:1132–1138. https://doi.org/10.1016/j.jaci.2013.08.031

Article  PubMed  Google Scholar 

Dhar S, Kanwar AJ (1998) Epidemiology and clinical pattern of atopic dermatitis in a North Indian pediatric population. Pediatr Dermatol 15:347–351. https://doi.org/10.1046/j.1525-1470.1998.1998015347.x

Article  CAS  PubMed  Google Scholar 

Silverberg JI, Simpson B, Abuabara K et al (2023) Prevalence and burden of atopic dermatitis involving the head, neck, face, and hand: a cross sectional study from the TARGET-DERM AD cohort. J Am Acad Dermatol 89:519–528. https://doi.org/10.1016/j.jaad.2023.04.052

Article  PubMed  Google Scholar 

Lio PA, Wollenberg A, Thyssen JP et al (2020) Impact of atopic dermatitis lesion location on quality of life in adult patients in a real-world study. J Drugs Dermatol 19:943–948. https://doi.org/10.36849/JDD.2020.5422

Article  PubMed  Google Scholar 

Guglielmo A, Sechi A, Patrizi A et al (2021) Head and neck dermatitis, a subtype of atopic dermatitis induced by Malassezia spp: clinical aspects and treatment outcomes in adolescent and adult patients. Pediatr Dermatol 38:109–114. https://doi.org/10.1111/pde.14437

Article  PubMed  Google Scholar 

Atherton DJ (2003) Topical corticosteroids in atopic dermatitis. BMJ 327:942–943

Article  PubMed  PubMed Central  Google Scholar 

Hajar T, Leshem YA, Hanifin JM et al (2015) A systematic review of topical corticosteroid withdrawal (“steroid addiction”) in patients with atopic dermatitis and other dermatoses. J Am Acad Dermatol 72:541-549.e2. https://doi.org/10.1016/j.jaad.2014.11.024

Article  CAS  PubMed  Google Scholar 

Wollenberg A, Lio P, Kleyn E et al (2022) Improvement of head and neck symptoms in patients with atopic dermatitis treated with baricitinib based on five phase III clinical trials. Eur J Dermatol 32:522–529. https://doi.org/10.1684/ejd.2022.4280

Article  CAS  PubMed  Google Scholar 

Navarro-Triviño FJ, Ayén-Rodríguez Á (2022) Study of hypersensitivity to Malassezia furfur in patients with atopic dermatitis with head and neck pattern: is it useful as a biomarker and therapeutic indicator in these patients? Life (Basel) 12:299. https://doi.org/10.3390/life12020299

Article  CAS  PubMed  Google Scholar 

Ashcroft DM, Dimmock P, Garside R et al (2005) Efficacy and tolerability of topical pimecrolimus and tacrolimus in the treatment of atopic dermatitis: meta-analysis of randomised controlled trials. BMJ 330:516. https://doi.org/10.1136/bmj.38376.439653.D3

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wollenberg A, Christen-Zäch S, Taieb A et al (2020) ETFAD/EADV Eczema task force 2020 position paper on diagnosis and treatment of atopic dermatitis in adults and children. J Eur Acad Dermatol Venereol 34:2717–2744. https://doi.org/10.1111/jdv.16892

Article  CAS  PubMed  Google Scholar 

Fishbein AB, Silverberg JI, Wilson EJ, Ong PY (2020) Update on atopic dermatitis: diagnosis, severity assessment, and treatment selection. J Allergy Clin Immunol Pract 8:91–101. https://doi.org/10.1016/j.jaip.2019.06.044

Article  PubMed  Google Scholar 

Paller AS, Siegfried EC, Thaçi D et al (2020) Efficacy and safety of dupilumab with concomitant topical corticosteroids in children 6 to 11 years old with severe atopic dermatitis: a randomized, double-blinded, placebo-controlled phase 3 trial. J Am Acad Dermatol 83:1282–1293. https://doi.org/10.1016/j.jaad.2020.06.054

Article  CAS  PubMed  Google Scholar 

Soria A, Du-Thanh A, Seneschal J et al (2019) Development or exacerbation of head and neck dermatitis in patients treated for atopic dermatitis with dupilumab. JAMA Dermatol 155:1312–1315. https://doi.org/10.1001/jamadermatol.2019.2613

Article  PubMed  PubMed Central  Google Scholar 

Kozera E, Stewart T, Gill K et al (2022) Dupilumab-associated head and neck dermatitis is associated with elevated pretreatment serum Malassezia-specific IgE: a multicentre, prospective cohort study. Br J Dermatol 186:1050–1052. https://doi.org/10.1111/bjd.21019

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jo CE, Finstad A, Georgakopoulos JR et al (2021) Facial and neck erythema associated with dupilumab treatment: a systematic review. J Am Acad Dermatol 84:1339–1347. https://doi.org/10.1016/j.jaad.2021.01.012

Article  CAS  PubMed  Google Scholar 

Muzumdar S, Zubkov M, Waldman R et al (2020) Characterizing dupilumab facial redness in children and adolescents: a single-institution retrospective chart review. J Am Acad Dermatol 83:1520–1521. https://doi.org/10.1016/j.jaad.2020.06.1003

Article  CAS  PubMed  Google Scholar 

Dybała A, Sernicola A, Gomes V et al (2022) Dupilumab facial redness: histologic characterization on a series of four cases. Immunotherapy 14:183–188. https://doi.org/10.2217/imt-2021-0122

Article  CAS  PubMed  Google Scholar 

Russo F, Cioppa V, Cartocci A et al (2024) Dupilumab and atopic dermatitis flares: an observational study to identify common clinical features in patients who have exacerbations despite biological therapy. Dermatitis 35:107–109. https://doi.org/10.1089/derm.2023.0011

Article  PubMed  Google Scholar 

Zhang E, Tanaka T, Tajima M et al (2011) Characterization of the skin fungal microbiota in patients with atopic dermatitis and in healthy subjects. Microbiol Immunol 55:625–632. https://doi.org/10.1111/j.1348-0421.2011.00364.x

Article